Mr. Rosenman has nearly 15-years executive experience in the health and wellness sectors, including weight loss, cosmetics skincare and nutrition, both Rx and OTC. Expertise areas include strategic market and product planning and corporate development (evaluation, recommendation and execution of strategic alliances and acquisitions). A MBA graduate of the Sweigart School of Business at Rider University, Rosenman devotes a portion of time back to the collegiate community as a graduate-level adjunct professor for healthcare marketing, consumer behavior and strategic planning. He has several published works in the field of U.S health and wellness, including a focus on how nutritional ingredients will transition into Rx ...More space, specifically with lipd and herbal managment. His current professional role is with one of the fastest growing nutritional companies in the U.S. which also produces Rx and OTC products. He has served as an advisory board member to various organizations in the healthcare field, from venture start-ups to top global enterprises. Mr. Rosenman is a Senior Advisor with Guidepoint Global and is called upon by large institutional investors for insight and expert opinion on healthcare market opportunities (to date he has advised on more than $2 billion USD of related transactions/funding). **I receive NO compensation of any kind for writing articles - any stock ownership is always disclosed on the editorial page**
- Description: Company executive. Trading frequency: Not Trading
- Interests: Stocks - long, Stocks - short
Currently, there is no company profile for Steve Rosenman.
Currently, there are no blog details for Steve Rosenman.
Currently, there are no book details for Steve Rosenman.
Latest Comments more »
- i'll be out of pocket next ... on Italian OTC Fish Oil Study Has No Bearing On Va...
- just don't want to and cann... on Italian OTC Fish Oil Study Has No Bearing On Va...
- Not saying at all JB is not... on Italian OTC Fish Oil Study Has No Bearing On Va...
- For the record, just about ... on Italian OTC Fish Oil Study Has No Bearing On Va...
- No, b/c the CEO is a nice g... on Italian OTC Fish Oil Study Has No Bearing On Va...
Latest comments on Steve Rosenman's Articles
- DNDNLONG on The Price May Be Increasing For An Amarin Buyout
- stephenhandal on The Price May Be Increasing For An Amarin Buyout
- BrandonUK07 on The Price May Be Increasing For An Amarin Buyout
- Not_Quite_Pheidipp... on A Top Biotech Stock To Own In 2013
- slackyhacky on A Top Biotech Stock To Own In 2013